Myomo, Inc. (MYO)
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
$145.18M
Mr. Paul R. Gudonis
87.00
Boston, MA
Jun 12, 2017
-20.87
$-0.23
0.95
2.10
-33.22%
-22.18
-0.61
20.01
5.87
1.62
-51.39%
-86.30%
Similar stocks (11)
enVVeno Medical Corporation
NVNO
Rapid Micro Biosystems, Inc.
RPID
Nexalin Technology, Inc.
NXL
IRIDEX Corporation
IRIX
Nuwellis, Inc.
NUWE
INVO Bioscience, Inc.
INVO
Bluejay Diagnostics, Inc.
BJDX
ReShape Lifesciences Inc.
RSLS
Heart Test Laboratories, Inc.
HSCS
Bone Biologics Corporation
BBLG
Motus GI Holdings, Inc.
MOTS
ETF Exposure (1)
iShares Micro-Cap ETF
IWC
0.03098%
Similar stocks (11)
enVVeno Medical Corporation
NVNO
Rapid Micro Biosystems, Inc.
RPID
Nexalin Technology, Inc.
NXL
IRIDEX Corporation
IRIX
Nuwellis, Inc.
NUWE
INVO Bioscience, Inc.
INVO
Bluejay Diagnostics, Inc.
BJDX
ReShape Lifesciences Inc.
RSLS
Heart Test Laboratories, Inc.
HSCS
Bone Biologics Corporation
BBLG
Motus GI Holdings, Inc.
MOTS
ETF Exposure (1)
iShares Micro-Cap ETF
IWC
0.03098%